We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+10.69%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.63B
AUM Growth
+$354M
Cap. Flow
+$42.2M
Cap. Flow %
0.91%
Top 10 Hldgs %
6.93%
Holding
1,360
New
97
Increased
499
Reduced
329
Closed
106

Top Buys

Rank Stock Value
1
PHIN icon
Phinia Inc
PHIN
+$19.2M
2
TGNA
TEGNA Inc
TGNA
+$16.8M
3
KSS icon
Kohl's
KSS
+$15M
4
CENTA icon
Central Garden & Pet Co Class A
CENTA
+$14.5M
5
ADNT icon
Adient
ADNT
+$12.1M

Sector Composition

Rank Sector Weight
1 Financials 27.28%
2 Consumer Discretionary 14%
3 Industrials 12.72%
4 Technology 9.9%
5 Healthcare 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGAN icon
1026
eGain
EGAN
$201M
$234K 0.01%
45,900
+22,700
+98% +$146K
SOND
1027
DELISTED
Sonder
SOND
$234K 0.01%
50,000
-10,000
-17% -$44.1K
JILL icon
1028
J. Jill
JILL
$283M
$232K 0.01%
9,400
-9,000
-49% -$293K
NPCE icon
1029
Neuropace
NPCE
$506M
$231K 0.01%
33,200
CMLS
1030
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$231K 0.01%
176,180
+804
+0.5% +$1.38K
AMTX icon
1031
Aemetis
AMTX
$124M
$230K 0.01%
99,900
-59,500
-37% -$167K
CZFS icon
1032
Citizens Financial Services
CZFS
$387M
$230K 0.01%
+3,948
New +$198K
RDW icon
1033
Redwire
RDW
$3.25B
$229K 0.01%
33,400
-135,000
-80% -$891K
ACRS icon
1034
Aclaris Therapeutics
ACRS
$869M
$229K 0.01%
199,119
+48,419
+32% +$59.4K
TAIT
1035
DELISTED
Taitron Components
TAIT
$228K ﹤0.01%
78,200
LVLU icon
1036
Lulu's Fashion Lounge
LVLU
$52.3M
$227K ﹤0.01%
9,473
+946
+11% +$21.2K
MYPS icon
1037
PLAYSTUDIOS Inc
MYPS
$90.1M
$226K ﹤0.01%
+149,700
New +$264K
EHTH icon
1038
eHealth
EHTH
$43.9M
$224K ﹤0.01%
55,000
-20,000
-27% -$86.4K
AP icon
1039
Ampco-Pittsburgh
AP
$193M
$223K ﹤0.01%
111,582
-49,050
-31% -$82.2K
SKYE icon
1040
Skye Bioscience
SKYE
$18.3M
$223K ﹤0.01%
+57,000
New +$320K
SVT
1041
DELISTED
Servotronics
SVT
$222K ﹤0.01%
19,653
ASMB icon
1042
Assembly Biosciences
ASMB
$529M
$220K ﹤0.01%
14,500
BCIC
1043
BCP Investment Corp
BCIC
$92.9M
$219K ﹤0.01%
11,820
IRD
1044
Opus Genetics
IRD
$302M
$217K ﹤0.01%
165,751
+2,010
+1% +$3.1K
ACCS
1045
ACCESS Newswire
ACCS
$26.2M
$217K ﹤0.01%
18,168
ASYS icon
1046
Amtech Systems
ASYS
$272M
$217K ﹤0.01%
37,400
AMPX icon
1047
Amprius Technologies
AMPX
$1.73B
$216K ﹤0.01%
195,000
UG icon
1048
United-Guardian
UG
$33.5M
$214K ﹤0.01%
13,466
SPCE icon
1049
Virgin Galactic
SPCE
$398M
$214K ﹤0.01%
+35,000
New +$234K
BCOV
1050
DELISTED
Brightcove, Inc.
BCOV
$213K ﹤0.01%
98,716
+40,000
+68% +$89.4K

Similar funds

Bridgeway Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Bridgeway Capital Management held 1,360 positions worth $4.63B, up 8.3% from $4.27B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.

Bridgeway Capital Management's Q3 2024 filing shows 97 new, 499 increased, 329 reduced and 106 closed positions. Its largest new stake was Phinia Inc: 427,196 shares worth $19.7M. The largest sale was Abercrombie & Fitch, an estimated $11M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q3 2024 buy was Phinia Inc: 427,196 shares worth $19.7M.
  • Bridgeway Capital Management added most to Central Garden & Pet Co Class A in Q3 2024, an estimated $14.5M increase.
  • Bridgeway Capital Management's biggest Q3 2024 reduction was Abercrombie & Fitch, cutting an estimated $11M.
  • Bridgeway Capital Management fully exited CleanSpark in Q3 2024, selling an estimated $7.03M.
  • Bridgeway Capital Management's ten largest holdings make up 6.9% of its $4.63B portfolio in Q3 2024.
  • Bridgeway Capital Management opened 97 new positions and closed 106 in Q3 2024.
  • Bridgeway Capital Management's portfolio value rose 8.3% quarter-over-quarter to $4.63B.

Based on Bridgeway Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.